Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Calcium mandelate |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Ormetoprin |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Pipemidic acid |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Fosfomycin (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Methenamine (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Nitrofurantoin (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Urinary anti-infective |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Trimethoprim (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Acetohydroxamic acid (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Mandelic acid (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
antimikrobielle urinvejslægemidler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Nitrofuran derivative (substance) |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Methenamin |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 80 mg/400 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 160 mg/800 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/80 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml koncentrat til infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml sukkerfri suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Trimethoprim 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Trimethoprim 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
trimethoprim 50 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
trimethoprim 20 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Product containing sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
polymyxin B-sulfat + trimethoprim øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
polymyxin B-sulfat + trimethoprim øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Trimethoprim 10 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Product containing trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
trimethoprim + sulfamethoxazol + phenazopyridinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
polymyxin B-sulfat + trimethoprimsulfat 10.000 enheder/1 mg opløsning til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim 200 mg/40 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim tablet a 400 mg/80 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
sulfamethoxazol + trimethoprim tablet a 800 mg/160 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml infusionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Polymyxin b sulfate + trimethoprim sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Product containing polymyxin B and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|
Nitroxoline |
Is a |
False |
Antiinfektiøst middel til brug i urinvejene |
Inferred relationship |
Some |
|